Navitor Pharmaceuticals' Series C Round

Navitor Pharmaceuticals raised a round of funding on March 20, 2018.

Navitor Pharmaceuticals, formerly Calorics, is a biopharmaceutical company developing medicines by targeting cellular nutrient signaling pathways. The company's proprietary drug discovery platform tar…

Articles about Navitor Pharmaceuticals' Series C Round: